Cargando…
HMGB2 upregulation promotes the progression of hepatocellular carcinoma cells through the activation of ZEB1/vimentin axis
BACKGROUND: High mobility group box 2 (HMGB2) is abnormally expressed in human cancers and participated in multiple biological behaviors, such as proliferation, invasion and prognosis. However, its role in hepatocellular carcinoma (HCC) is largely unknown. METHODS: In clinical sample analysis, 62 HC...
Autores principales: | Lu, Kai, Zhao, Teng, Yang, Lixue, Liu, Yang, Ruan, Xiang, Cui, Longjiu, Zhang, Yongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643579/ https://www.ncbi.nlm.nih.gov/pubmed/37969822 http://dx.doi.org/10.21037/jgo-23-447 |
Ejemplares similares
-
YAP promotes autophagy and progression of gliomas via upregulating HMGB1
por: Zhao, Min, et al.
Publicado: (2021) -
Oncogenic ZEB2/miR-637/HMGA1 signaling axis targeting vimentin promotes the malignant phenotype of glioma
por: Zeng, Yu, et al.
Publicado: (2021) -
Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression
por: Bi, Man Ru, et al.
Publicado: (2014) -
Inhibition of HMGB1 Suppresses Hepatocellular Carcinoma Progression via HIPK2-Mediated Autophagic Degradation of ZEB1
por: Zhu, Wei, et al.
Publicado: (2021) -
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
por: Zeng, Kai, et al.
Publicado: (2023)